Please use this identifier to cite or link to this item: https://doi.org/10.1038/ncomms15028
DC FieldValue
dc.titleEngineered probiotic Escherichia coli can eliminate and prevent Pseudomonas aeruginosa gut infection in animal models
dc.contributor.authorHwang, I.Y
dc.contributor.authorKoh, E
dc.contributor.authorWong, A
dc.contributor.authorMarch, J.C
dc.contributor.authorBentley, W.E
dc.contributor.authorLee, Y.S
dc.contributor.authorChang, M.W
dc.date.accessioned2020-09-04T03:41:02Z
dc.date.available2020-09-04T03:41:02Z
dc.date.issued2017
dc.identifier.citationHwang, I.Y, Koh, E, Wong, A, March, J.C, Bentley, W.E, Lee, Y.S, Chang, M.W (2017). Engineered probiotic Escherichia coli can eliminate and prevent Pseudomonas aeruginosa gut infection in animal models. Nature Communications 8 : 15028. ScholarBank@NUS Repository. https://doi.org/10.1038/ncomms15028
dc.identifier.issn2041-1723
dc.identifier.urihttps://scholarbank.nus.edu.sg/handle/10635/174427
dc.description.abstractBacteria can be genetically engineered to kill specific pathogens or inhibit their virulence. We previously developed a synthetic genetic system that allows a laboratory strain of Escherichia coli to sense and kill Pseudomonas aeruginosa in vitro. Here, we generate a modified version of the system, including a gene encoding an anti-biofilm enzyme, and use the probiotic strain Escherichia coli Nissle 1917 as host. The engineered probiotic shows in vivo prophylactic and therapeutic activity against P. aeruginosa during gut infection in two animal models (Caenorhabditis elegans and mice). These findings support the further development of engineered microorganisms with potential prophylactic and therapeutic activities against gut infections. © 2017 The Author(s).
dc.publisherNature Publishing Group
dc.sourceUnpaywall 20200831
dc.subjectalanine racemase
dc.subjectprobiotic agent
dc.subjectprobiotic agent
dc.subjectbacterium
dc.subjectbiofilm
dc.subjectenzyme activity
dc.subjectgenetic engineering
dc.subjectinfectivity
dc.subjectnematode
dc.subjectpathogen
dc.subjectprobiotics
dc.subjectrodent
dc.subjectvirulence
dc.subjectanimal experiment
dc.subjectanimal model
dc.subjectanimal tissue
dc.subjectArticle
dc.subjectbacterial strain
dc.subjectCaenorhabditis elegans
dc.subjectcontrolled study
dc.subjectdrug efficacy
dc.subjectEscherichia coli
dc.subjectEscherichia coli Nissle 1917
dc.subjectfemale
dc.subjectgenetic engineering
dc.subjectin vivo study
dc.subjectinfection prevention
dc.subjectintestine infection
dc.subjectmouse
dc.subjectnonhuman
dc.subjectPseudomonas infection
dc.subjecttreatment outcome
dc.subjectanimal
dc.subjectdisease model
dc.subjectEscherichia coli
dc.subjectgastroenteritis
dc.subjectgenetic engineering
dc.subjectgenetics
dc.subjectInstitute for Cancer Research mouse
dc.subjectmicrobiology
dc.subjectpathogenicity
dc.subjectprocedures
dc.subjectPseudomonas aeruginosa
dc.subjectPseudomonas infection
dc.subjecttransgenic microorganism
dc.subjectvirulence
dc.subjectAnimalia
dc.subjectBacteria (microorganisms)
dc.subjectCaenorhabditis elegans
dc.subjectEscherichia coli
dc.subjectEscherichia coli Nissle 1917
dc.subjectMus
dc.subjectPseudomonas aeruginosa
dc.subjectAnimals
dc.subjectCaenorhabditis elegans
dc.subjectDisease Models, Animal
dc.subjectEscherichia coli
dc.subjectFemale
dc.subjectGastroenteritis
dc.subjectGenetic Engineering
dc.subjectMice
dc.subjectMice, Inbred ICR
dc.subjectMicroorganisms, Genetically-Modified
dc.subjectProbiotics
dc.subjectPseudomonas aeruginosa
dc.subjectPseudomonas Infections
dc.subjectVirulence
dc.typeArticle
dc.contributor.departmentBIOCHEMISTRY
dc.contributor.departmentPAEDIATRICS
dc.description.doi10.1038/ncomms15028
dc.description.sourcetitleNature Communications
dc.description.volume8
dc.description.page15028
Appears in Collections:Elements
Staff Publications

Show simple item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
10_1038_ncomms15028.pdf1.37 MBAdobe PDF

OPEN

NoneView/Download

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.